Advances in asthma in 2017: Mechanisms, biologics, and genetics
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 142 (5) , 1423-1436
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Research Institute at Nationwide Children's Hospital
- NIH
- Patient-Centered Outcomes Research Institute
This publication has 94 references indexed in Scilit:
- β-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant TH2/TH17 responsesJournal of Allergy and Clinical Immunology, 2017
- Fish oil supplementation during pregnancy and allergic respiratory disease in the adult offspringJournal of Allergy and Clinical Immunology, 2017
- CD151, a laminin receptor showing increased expression in asthmatic patients, contributes to airway hyperresponsiveness through calcium signalingJournal of Allergy and Clinical Immunology, 2017
- Anaphylactic reactions associated with omalizumab administration: Analysis of a case-control studyJournal of Allergy and Clinical Immunology, 2016
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialThe Lancet, 2016
- Measuring the corticosteroid responsiveness endophenotype in asthmatic patientsJournal of Allergy and Clinical Immunology, 2015
- DNA methylation and childhood asthma in the inner cityJournal of Allergy and Clinical Immunology, 2015
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumabJournal of Allergy and Clinical Immunology, 2014
- ORMDL3 Transgenic Mice Have Increased Airway Remodeling and Airway Responsiveness Characteristic of AsthmaThe Journal of Immunology, 2014